PH011 — Cognitive Clarity
Capacity to maintain clear, organised mental processing without excessive fog or confusion.
How clear and organised thinking feels — distinct from attention stability or raw mental energy.
Therapeutic areas: TA001 ★TA002TA003TA004TA005TA006TA007
Provenance: Core Version 1 registry phenome for mental processing clarity (distinct from Focus/Attention Stability PH001 and Cognitive Energy PH004). Enriched with cross-system oxidative and micronutrient biology. (origin: BRAIN)
Related phenomes: PH001 — Focus / Attention Stability, PH004 — Cognitive Energy Stability
External framework cross-references
RDoC domains
- Cognitive Systems — cognitive control / processing efficiency
DSM / ICD context
- Attention-deficit/hyperactivity disorder — cognitive symptoms
- Mild cognitive impairment
Foundational Evidence
Evidence Confidence: Low–Medium
Registry-level score for this phenome's foundational evidence stack — not Biology → Phenome Confidence on individual mechanism pages.
Oxidative-stress and omega-3 cognition reviews support biology→phenome; homocysteine and gut–estrogen links are mechanistic — clarity outcomes not isolated as primary endpoints on the stack.
Registry-level foundational evidence for this phenome. Mechanism pages link to phenome IDs and carry relationship-specific evidence — not duplicated here.
Construct landmark papers
- Derbyshire & Maes (2023) — Neuroinflammation and oxidative stress in ADHD — cognitive symptom construct context.
- Liu et al. (2014) — Homocysteine and cognitive function — clarity/processing efficiency framing.
Biology → phenome landmark papers
- Verlaet et al. (2019) — Oxidative stress biology linked to ADHD cognitive symptom domains.
- Collaboration (1998) — Homocysteine lowering and cognitive outcomes — biology→clarity linkage.
Nutrition → biology landmark papers
- Oulhaj et al. (2016) — Omega-3 supplementation and cognitive performance — human nutrition→cognition support.
- Watson et al. (2019) — Gut–brain signalling and cognitive health — microbiome nutrition context.
Connected mechanisms
- BRS-X(ECS-PM2) — Omega-3-Derived Endocannabinoidome Signalling (modulates · low)
BRS-X(Hormones)
- BRS-X(Hormones-PM1) — Oestrogen Signalling Stability (modulates · low-medium)
- BRS-X(Hormones-PM2) — Estrobolome Regulation (indirect · low-medium)
BRS1
- BRS1-FM2-PM5 — Acetylcholine Synthesis Support (modulates · medium)
- BRS1-FM3-PM6 — Neuronal Membrane DHA Incorporation (modulates · low-medium)
- BRS1-FM4-PM9 — Glutamate Clearance & Recycling (modulates · low)
BRS2
- BRS2-FM1-PM1 — Folate/B12-Dependent Homocysteine Remethylation (modulates · low-medium)
- BRS2-FM1-PM2 — Betaine/BHMT Remethylation (indirect · low)
- BRS2-FM1-PM3 — SAMe Synthesis (modulates · medium)
- BRS2-FM1-PM4 — Methionine Cycle Flux (modulates · low-medium)
- BRS2-FM3-PM7 — Phosphatidylcholine Formation (modulates · medium)
BRS3
- BRS3-FM1-PM1 — NF-kB Signalling Regulation (modulates · low-medium)
- BRS3-FM1-PM2 — Gut-Derived Inflammatory Signalling (modulates · low-medium)
- BRS3-FM2-PM3 — Nrf2-ARE Antioxidant Activation (modulates · low-medium)
- BRS3-FM2-PM4 — ROS Generation vs Clearance Balance (modulates · low-medium)
- BRS3-FM2-PM5 — Lipid Peroxidation Control (modulates · low-medium)
- BRS3-FM2-PM6 — Antioxidant Network Recycling (modulates · low-medium)
- BRS3-FM3-PM7 — Cytokine Network Modulation (modulates · low)
- BRS3-FM3-PM8 — Eicosanoid / SPM Balance (modulates · low-medium)